<html>
<head>PUBMED IDs for SAC2</head>
<body bgcolor='#C5F0F2'><h1>SAC2</h1><a href='https://pubmed.ncbi.nlm.nih.gov/9790748/'>Identification of a novel highly conserved gene in the centromeric part of the major histocompatibility complex.</a> October 29  1998<br><a href='https://pubmed.ncbi.nlm.nih.gov/11149963/'>Inhibition of melanoma tumor growth in vivo by survivin targeting.</a> January 10  2001<br><a href='https://pubmed.ncbi.nlm.nih.gov/15388447/'>Genomic approach to identification of mutations affecting caspofungin susceptibility in Saccharomyces cerevisiae.</a> September 25  2004<br><a href='https://pubmed.ncbi.nlm.nih.gov/16702945/'>Induction of melanoma cell apoptosis and inhibition of tumor growth using a cell-permeable Survivin antagonist.</a> May 17  2006<br><a href='https://pubmed.ncbi.nlm.nih.gov/17510430/'>Survivin, a member of the inhibitor of apoptosis family, is induced by photodynamic therapy and is a target for improving treatment response.</a> May 19  2007<br><a href='https://pubmed.ncbi.nlm.nih.gov/17973544/'>Protein phosphorylation in irradiated human melanoma cells.</a> November 2  2007<br><a href='https://pubmed.ncbi.nlm.nih.gov/23640047/'>Survivin promotion of melanoma metastasis requires upregulation of Î±5 integrin.</a> December 18  2013<br></body></html>
